Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
about
Exosomal miRNAs as cancer biomarkers and therapeutic targetsExtracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionDiagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic reviewNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesMolecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment OutcomesDecoding the Secret of Cancer by Means of Extracellular VesiclesWhen Prostate Cancer Circulates in the BloodstreamWhole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer.Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersThe functions and clinical applications of tumor-derived exosomesSuppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNAExosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression.Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancerMiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma.Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.MicroRNA-375 plays a dual role in prostate carcinogenesisPlasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerThe emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy.Exosomes in cancer: small particle, big player.Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal CarcinomaMeeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium.A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate CancerPlasma extracellular RNA profiles in healthy and cancer patients.Prostasomes as a source of diagnostic biomarkers for prostate cancer.Versatile roles of extracellular vesicles in cancerExosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer.MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discoveryCommon Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer.Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke.Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.Exosomes: From Garbage Bins to Promising Therapeutic Targets.Identification of prostate cancer biomarkers in urinary exosomes.Functional significance of aberrantly expressed microRNAs in prostate cancer.
P2860
Q26738660-4167A9DE-54A8-4F16-A1F9-5DC88E943114Q26742027-61AB9748-38C0-479D-8EB5-B0FCB9D2E624Q26748872-5AC5667A-6153-4DB8-9CC4-702CD03146EEQ26748881-D6ECD6B0-E527-4E31-A64D-46933E35E3FCQ26765922-DEE9F215-5F35-408C-920D-C68325565E2BQ26767179-44ED0100-EE7F-4852-B922-98332310A2C3Q26768470-F7FC5BEB-C165-4725-867E-1BDD6819E4D7Q27853196-A623C5FE-8B08-48DB-A747-DBE682709165Q28075610-580445BC-51E0-4125-810A-20FEFD5F2372Q30361738-5CB034D4-0941-4B1C-9562-928FE159215CQ30855032-98DE48E9-BF62-4465-A831-30095ADDB5EFQ33363486-00172513-83D8-49C7-99E7-272E47E4CFBFQ33644807-29E4B083-5D8A-4A3C-A016-0C31EB0BB7BCQ33648610-DAF99EA5-73F9-46EE-B937-3ACC4515593CQ33829967-597A18D4-E559-448D-8A4A-FD3A72A5C1C2Q35510445-90455FE7-5C4C-4E12-8612-7409D4CF204CQ35606022-AF5C6ACF-7B7B-4B6C-8CAF-A5B951384B04Q35615320-314156C6-C22C-4AC8-BDA2-D8D2EFD97947Q35807725-8E26B3EF-51C6-4AE2-B271-B8511C3015F5Q35834473-20CCEFE3-BFAE-4B21-8608-41ECCADB7F15Q35875417-BE6CB135-F80B-4316-ADAB-3F81F9A59684Q36006450-444363FE-CA60-4416-B2D0-E314BB3D0F7EQ36407203-DDAB3C47-C91E-40B3-AEDF-6EC34212CCFBQ36501082-7064C010-F953-486F-99F1-9C65BD696753Q36737927-952D6F76-BA98-44A7-84E0-F26E6787EDEFQ36737955-1121F657-0C5B-4040-A388-23BF95330699Q36782329-6B20DCDF-FEF3-4D31-8F8B-8417C312E7E4Q36902655-2EC5B7D0-B76F-4F38-87A3-40F1AD0805E9Q37004332-8957826F-3371-49D5-8289-0CA238FEF564Q37113174-79BD9330-DC02-4DA2-80E3-1531D71D0B36Q37134564-27813859-FB5E-42E8-82A9-BF8D322FAE2BQ37159960-111A3BDE-62A7-42B8-A886-AAA5775F40DCQ37392579-AD8F0A1C-2C37-4EFF-B611-076EE2FD0332Q37408814-B7800532-40C0-4C20-AB4E-ACAE63A421ABQ37644574-893D551D-F96A-4782-9145-7127FE9E7B50Q37667327-AF7ADA8F-6991-4325-918E-B328A1AED9C7Q37706539-5F7FEDBC-76B8-46FB-B09A-8B79F7660270Q37729108-FAC01C77-A56D-45A4-914C-04ECB2099FD3Q38286457-D88777B6-30FA-4732-98D0-57DCF5675E8EQ38323461-212B9436-6E6B-4955-8CE4-DBF646B27C60
P2860
Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@ast
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@en
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@nl
type
label
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@ast
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@en
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@nl
prefLabel
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@ast
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@en
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@nl
P2093
P2860
P50
P1433
P1476
Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer
@en
P2093
Brian A Costello
Debashis Nandy
Fernando Quevedo
Graham H Bevan
Liang Wang
Lisa Boardman
Manish Kohli
Meihua Liang
P2860
P356
10.1016/J.EURURO.2014.07.035
P407
P577
2014-08-14T00:00:00Z